Deepak Nitrite FY26 Revenue Declines to ₹7,947 Cr, Board Recommends ₹7.50 Dividend

CHEMICALS
Whalesbook Corporate News Logo
AuthorIshaan Verma|Published at:
Deepak Nitrite FY26 Revenue Declines to ₹7,947 Cr, Board Recommends ₹7.50 Dividend

Deepak Nitrite reported a dip in consolidated revenue to ₹7,947 crore for FY26 from ₹8,366 crore in FY25. EBITDA and PAT also saw a decline. The company recommended a final dividend of ₹7.50 per share.

Deepak Nitrite's FY26 Revenue Falls Amidst Global Chemical Industry Headwinds

Consolidated revenue for FY 2025-26 stood at ₹ 7,947 crore, a decrease from ₹ 8,366 crore in the previous fiscal year. Profit After Tax (PAT) was ₹ 551 crore compared to ₹ 697 crore in FY 2024-25.

Reader Takeaway: Financials impacted by global issues, but long-term projects offer growth potential.

What just happened

Deepak Nitrite announced its financial results for the fiscal year 2025-26, reporting a consolidated revenue of ₹ 7,947 crore. This represents a decline from ₹ 8,366 crore in FY 2024-25. The company's EBITDA (excluding exceptional items) also saw a reduction, coming in at ₹ 1,041 crore compared to ₹ 1,176 crore in the prior year. Profit After Tax (PAT) for FY26 was ₹ 551 crore, down from ₹ 697 crore in FY25. The Earnings Per Share (EPS) stood at ₹ 40.36, a decrease from ₹ 51.12.

Why this matters

Despite the year-on-year decline in revenue and profitability, the company's operational performance remained robust in key segments. The Phenolics Business, comprising Phenol, Cumene, and IPA plants, maintained high utilization rates above 150%. The Advanced Intermediates segment navigated market pressures through strategic product mix optimization. The board has recommended a final dividend of ₹ 7.50 per equity share for FY 2025-26.

The backstory

The financial performance was significantly impacted by challenges within the global chemical industry. These include volatility in feedstock prices, ongoing trade tensions, and intense competitive pricing pressures.

What changes now

Deepak Nitrite is focusing on a strategic shift from scale-led expansion to value-led integrated growth. The company is advancing its integrated Cumene-to-Polycarbonate value chain project, with equipment from a German plant being shipped for commissioning by 2029. A significant capex pipeline of approximately ₹ 11,500 crore is planned for expansions in phenol, acetone, and specialty chemicals.

Risks to watch

Investors need to monitor the impact of global chemical industry headwinds, including feedstock price fluctuations and trade dynamics. The successful execution and timely commissioning of the Polycarbonate resin project and other expansion plans are critical for future growth.

Peer comparison

While specific peer comparisons are not detailed in the filing, the company's performance reflects broader trends in the global chemical sector, which has faced margin pressures due to supply chain issues and demand fluctuations.

Context metrics (time-bound)

Consolidated revenue for FY 2025-26: ₹ 7,947 Cr
Consolidated EBITDA for FY 2025-26: ₹ 1,041 Cr
Profit After Tax for FY 2025-26: ₹ 551 Cr
EPS for FY 2025-26: ₹ 40.36
Recommended Dividend: ₹ 7.50 per share

What to track next

Investors should closely watch the company's progress on its strategic projects, particularly the Polycarbonate resin plant, and its ability to adapt to evolving market conditions and pricing pressures in the chemical industry.

Disclaimer:This article is published for informational purposes only. While reasonable efforts are made to ensure accuracy, completeness, and timeliness, readers are encouraged to independently verify information before making any decisions based on the content. The views and information presented are subject to editorial review and may be updated without notice.